About
Corporate Values
Management Team
Board of Directors
Scientific Advisory Board
Pipeline
Fexuprazan
NG101
Therapy Areas
Erosive Esophagitis
Gastroparesis
Investors
Media Resources
Contact Us
View Careers on LinkedIn
About
Corporate Values
Management Team
Board of Directors
Scientific Advisory Board
Pipeline
Fexuprazan
NG101
Therapy Areas
Erosive Esophagitis
Gastroparesis
Investors
Media Resources
Contact Us
View Careers on LinkedIn
Investors
Overview
Neurogastrx has raised a total of $125M in financing to date.
